Taking the Pulse of Health Care and Politics
With more health-related topics becoming politicized, it may be hard to keep politics out of the exam room.
As another U.S. presidential election approaches, Americans are once again readying themselves to discuss potentially polarizing political...
Online Exclusives
Possible Delays for Landmark Opioid Trial, U.S. Judge Denies Drug Companies’...
A growing list of drug makers, pharmacies, and distributors are facing lawsuits by states, counties, individuals, and municipalities for their roles in the opioid...
Insurers Introduce Plans to Cover Expensive Gene Therapies
Gene therapies – which may offer a one-time cure for patients with life-threatening and rare diseases– are among the most expensive treatments in the...
News
From the Blood Journals
Pretransplant Bridging With Blinatumomab Reduces MRD in Children With B-Cell Acute...
In a study of children with B-cell acute lymphocytic leukemia (B-ALL) who are about to undergo allogeneic hematopoietic cell transplantation (alloHCT), bridging with blinatumomab...
Certain Non-Hodgkin Lymphoma Subtypes Carry Higher Risk of Infection-Related Solid Tumor...
Various subtypes of non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) and marginal zone lymphoma (MZL), carry a risk for second infection-related solid...
Multimedia
Pulling Back the Curtain: Saad Z. Usmani, MD
In more from our interview with Saad Z. Usmani, MD, he shares life lessons learned throughout his career.
Pulling Back the Curtain: Anna Schuh, MD, PhD
In more from our interview with Anna Schuh, MD, PhD, she shares her experiences volunteering with hematology patients in Tanzania.
Robert Kreitman: Delayed Versus Concurrent Rituximab in Hairy Cell Leukemia
Robert Kreitman, MD, shares results from a new study suggesting patients with hairy cell leukemia should receive rituximab concurrently with frontline cladribine.
Tibor Kovacsovics: CX-01 Associated With High Response Rates in Older Patients...
Tibor Kovacsovics, MD, discusses CX-01, a heparin derivative that induced high response rates in older patients newly diagnosed with acute myeloid leukemia.
On Location
From ASH Meeting on Hematologic Malignancies: How would you treat relapsed/refractory myeloma after transplant?
During their presentations, MHM speakers will be asking the audience how they would respond to...
From ASH Meeting on Hematologic Malignancies: What are the approved options for relapsed marginal zone lymphoma?
During their presentations, MHM speakers will be asking the audience how they would respond to...
From ASH Meeting on Hematologic Malignancies: How would you treat this patient with high-grade MDS?
During their presentations, MHM speakers will be asking the audience how they would respond to...
Isatuximab Combination Improves Progression-Free Survival in Pretreated Myeloma
The combination of isatuximab and pomalidomide plus dexamethasone (Pd) extended progression-free survival (PFS) to 11.5...
Guadecitabine Performs No Better Than Other Hypomethylating Agents in Treatment-Naïve Acute Myeloid Leukemia
Results from a large phase III trial of the hypomethylating agent (HMA) guadecitabine in patients...
Valoctocogene Roxaparvovec Continues to Improve Bleeding Outcomes in Patients with Hemophilia A
In three-year follow-up results from an ongoing phase I/II study of patients with hemophilia A,...
Latest Headlines
ASH Directions
ASH Sickle Cell Initiative Wins Top ASAE Prize, ASH-a-Palooza 2019 Announced, and more
ASH Sickle Cell Disease Initiative Wins Top ASAE Prize
The American Society of Hematology (ASH) is proud to have been named a 2019 Power of...
ASH Backs Palliative Blood Transfusions During Hospice Care, Announces 2019 Honorific and Mentor Award...
ASH Backs the Use of Palliative Blood Transfusions During Hospice Care for Symptom Improvement
The American Society of Hematology (ASH) has announced its support...
Remembering Eugene Frenkel, AMA Announces Reimagining Residency Initiative Award Recipients, and more
Remembering Eugene P. Frenkel (1929 – 2019)
Eugene P. Frenkel, MD, a National Cancer Institute investigator known for his research linking vitamin B12 metabolism and...
Remembering Gustave Eisemann, Cigall Kadoch Wins 2019 Wachtel Cancer Research Prize, and more
Remembering Gustave Eisemann (1926 – 2019)
Gustave Eisemann, MD, passed away on May 26, 2019.
Born in Halberstadt, Germany, Dr. Eisemann came to the U.S. in...
Steven Rosenberg Receives Szent-Györgyi Prize, FDA Names Elizabeth Jungman Head of Regulatory Policy, and...
Steven A. Rosenberg Receives Szent-Györgyi Prize
The National Foundation for Cancer Research has awarded Steven A. Rosenberg, MD, PhD, the 2019 Szent-Györgyi Prize for Progress...
Taking the Pulse of Health Care and Politics
With more health-related topics becoming politicized, it may be hard to keep politics out of the exam room.
As another U.S. presidential election approaches, Americans...
The Spy Next Door?
Academic institutions and government organizations strive to prevent research espionage while maintaining open scientific collaborations
For decades, the U.S. has fostered international research collaborations with...
In Myeloma, New Drugs, Skyrocketing Price Tags
In late February, seven pharmaceutical executives were called before the U.S. Senate Finance Committee to testify about the prices of brand-name prescription drugs, which...
